By NewsDesk  @bactiman63 Cambridge, MA  biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, Inc., announced Friday that the U.S. Food and Drug Administration’s...

In this news podcast, I look at the success and progress of the Pfizer and Moderna vaccines and their situation concerning receiving and Emergency Use Authorization (EUA). Today, the Centers for Disease...

By NewsDesk  @bactiman63 Cambridge, MA biotechnology company, Moderna, Inc. announced today that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273,...

Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized,...

Clinical-stage, natural killer cell-based therapeutics company, NantKwest and  ImmunityBio, a privately-held immunotherapy company announced ImmunityBio has been selected to participate in Operation Warp...